Video

Balancing Work and Home Life Can Help Burnout for Pharmacy Technicians

Whitney Hummel, AAS, CPhT-Adv, CSPT, RYT, pharmacy operations coordinator at the Florida Cancer Specialists & Research Institute, discusses burnout for pharmacy technicians.

In a Pharmacy Times® interview, Whitney Hummel, AAS, CPhT-Adv, CSPT, RYT, pharmacy operations coordinator at the Florida Cancer Specialists & Research Institute, discusses burnout for pharmacy technicians.

She addresses the role of the COVID-19 pandemic in burnout, how to balance home- and work-life, and how pharmacists can address burnout in te workplace.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Related Content
Human fills a prior authorization form - Image credit: Maksim Shchur | stock.adobe.com
August 19th 2025

Alaska Law Implements Time Limits for Prior Authorization Decisions on Medication Coverage

Jim Ruble, PharmD, JD
Pharmacy Times, Pharmacy Focus Oncology Edition
August 19th 2025

Taletrectinib Takes Aim: A New Chapter in ROS1-Positive NSCLC

Alexandra Gerlach, Associate Editor Kevin Chen, PharmD Amanda Cass, PharmD, BCPS, BCOP
Magnifying glass highlighting Amazon Pharmacy website | Image Credit: © IB Photography - stock.adobe.com
August 19th 2025

Q&A: New Report Reveals Potential Shift from Brick-and-Mortar to Mail-Order Pharmacy

Alexandra Gerlach, Associate Editor
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
August 19th 2025

A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP
Multiple myeloma cells illustrated in the bone marrow | Image Credit: © Khella - stock.adobe.com
August 19th 2025

Bone Marrow Microenvironments Vary Widely in Multiple Myeloma, Study Finds

Alexandra Gerlach, Associate Editor
Test tube with blood sample for triglyceride test | Image Credit: jarun011 | stock.adobe.com
August 19th 2025

FDA Reviews Plozasiran: A Potential First-in-Class Therapy for Familial Chylomicronemia Syndrome

Danielle Valletti, Assistant Editor